CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 29, 2022 | Series Unknown | ¥100M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Jifeng Ventures | — | Series Unknown |